MONTEBAN 100 DIN 02431696
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | NARASIN 100 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 24-Jul-2015 |
|---|
| Current status date | 10-Oct-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NARASIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01902687 | MAXIBAN PREMIX | ELANCO CANADA LIMITED | Drug Premix | NARASIN 80 G; NICARBAZIN 80 G | Marketed |
| 00707538 | MONTEBAN 70 | ELANCO CANADA LIMITED | Drug Premix | NARASIN 70 G | Dormant |
| 02010038 | PREMELANGE 25/2 GRIL MEDICAMENTE (MONTEBAN) | LA COOP FEDEREE | Drug Premix | NARASIN 5.6 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23367 | 2020-03-20 | Supplement to a New Drug Submission (SNDS) | Removal of indication |
| 20120 | 2017-11-30 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 16131 | 2014-09-26 | Supplement to a New Drug Submission (SNDS) | NEW STRENGTH |
Request a quote for MONTEBAN 100
How to read a Canadian DIN record